The impact of delirium on cardiac surgery patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defines delirium as a disturbance in attention and awareness that develops over a short period and involves fluctuation in severity.

This profile is also accompanied by an additional disturbance in cognition (e.g., memory), which are not explained by a preexisting neurocognitive disorder. Arousal levels, such as those in patients in a coma, must also not be severely reduced. Finally, to make the diagnosis of delirium, there must be evidence that the disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal, exposure to a toxin, or due to multiple etiologies.

Delirium is common in patients undergoing cardiac surgery; with estimates ranging from 26% to 52%. In cardiac intensive care units, patients with delirium have more extended hospital and ICU stays; increased healthcare costs; and greater morbidity, mortality, and risk of cognitive decline. Additionally, the duration of delirium is an independent risk factor for worse cognition at long-term follow-up over 1 year. When delirium is recognized, tailored work-up and intervention for the underlying cause can reduce the duration of delirium and its negative consequences.

Source:
Journal reference:

Benjamin A., et al. (2024) Delirium in the Cardiac Patient. Cardiovascular Innovations and Applications. doi.org/10.15212/CVIA.2024.0028.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Progress in early detection and screening methods for pancreatic cancer